BNP Paribas Financial Markets’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.46M | Sell |
|
|||||
|
2025
Q2 | $4.3M | Buy |
|
|||||
|
2025
Q1 | $1.91M | Buy |
|
|||||
|
2024
Q4 | $1.58M | Buy |
|
|||||
|
2024
Q3 | $958K | Buy |
|
|||||
|
2024
Q2 | $265K | Sell |
|
|||||
|
2024
Q1 | $2.35M | Sell |
|
|||||
|
2023
Q4 | $5.42M | Buy |
|
|||||
|
2023
Q3 | $2.52M | Buy |
|
|||||
|
2023
Q2 | $1.72M | Sell |
|
|||||
|
2023
Q1 | $3.3M | Buy |
|
|||||
|
2022
Q4 | $1.6M | Sell |
|
|||||
|
2022
Q3 | $2.1M | Buy |
|
|||||
|
2022
Q2 | $267K | Buy |
|
|||||
|
2022
Q1 | $129K | Sell |
|
|||||
|
2021
Q4 | $564K | Buy |
|
|||||
|
2021
Q3 | $465K | Buy |
|
|||||
|
2021
Q2 | $50.5K | Buy |
|
|||||
|
2021
Q1 | $6.61K | Buy |
|
|||||
|
2020
Q4 | $53 | Hold |
|
|||||
|
2020
Q3 | $44 | Hold |
|
|||||
|
2020
Q2 | $39 | Sell |
|
|||||
|
2020
Q1 | $40 | Hold |
|
|||||
|
2019
Q4 | $54 | Sell |
|
|||||
|
2019
Q3 | $545 | Sell |
|
|||||
|
2019
Q2 | $734 | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $756 | Buy |
|
|||||
|
2018
Q3 | $1.23K | Hold |
|
|||||
|
2018
Q2 | $1.37K | Sell |
|
|||||
|
2018
Q1 | $66.1K | Sell |
|
|||||
|
2017
Q4 | $83.1K | Buy |
|
|||||
|
2017
Q3 | $46.6K | Sell |
|
|||||
|
2017
Q2 | $49.8K | Buy |
|
|||||
|
2017
Q1 | $36.8K | Sell |
|
|||||
|
2016
Q4 | $395K | Sell |
|
|||||
|
2016
Q3 | $594K | Buy |
|
|||||
|
2016
Q2 | $493K | Sell |
|
|||||
|
2016
Q1 | $511K | Buy |
|
|||||
|
2015
Q4 | $2.03M | Buy |
|
|||||
|
2015
Q3 | $1.27M | Buy |
|
|||||
|
2015
Q2 | $1.48M | Buy |
|
|||||
|
2015
Q1 | $511K | Sell |
|
|||||
|
2014
Q4 | $721K | Sell |
|
|||||
|
2014
Q3 | $1.52M | Buy |
|
|||||
|
2014
Q2 | $660K | Buy |
|
|||||
|
2014
Q1 | $189K | Buy |
|
|||||
|
2013
Q4 | $27.6K | Sell |
|
|||||
|
2013
Q3 | $792K | Sell |
|
|||||
|
2013
Q2 | $440K | Buy |
|